Metabolic Research, Inc. Elects Bradford van Siclen to its Board

Business Wire, Sept 2, 2008

LAS VEGAS -- Metabolic Research, Inc. (OTCBB:MTBR) announced today the election of Bradford van Siclen to its Board of Directors. Brad van Siclen has a MBA from New York University's Stern School of Business with emphasis on Finance and Accounting. His career includes Vice President, Investment Banking with Commonwealth Associates, Founder and Managing Director of the Investment Banking Department of Joseph Gunnar & Co, Managing Director, Sunrise Securities Corporation where he worked under the renowned trader, Nathan Low. In 2004 he became a partner in Bartholomew International Investments.

Metabolic Chairman and CEO Dr. David Summers said,"We are very pleased to have Brad come aboard utilizing his background in developing a solid financial foundation for future growth of the company and our signature product. We have successfully launched Stemulite and are looking forward to the Mr. Olympia Trade Show September 25-28th at the Orleans Casino where we will be introducing our new website.

For more information about Metabolic Research, Inc., see www.metabolicresearchinc.com. For more information about Metabolic's products, see www.stemulite.com.

This press release includes "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In addition to statements which explicitly describe such risks and uncertainties, readers are urged to consider statements labeled with the terms "believes," "belief," "expects," "intends," "anticipates," "will," or "plans" to be uncertain and forward looking. The forward-looking statements contained herein are also subject generally to other risks and uncertainties that are described from time to time in the company's reports and registration statements filed with the Securities and Exchange Commission.